Vaccine commercialization will benefit pharmaceutical filling industry

Due to COVID19 outbreak 2019,based on China's huge population, the further enhancement of residents' health awareness,and the promotion of vaccination willingness, China's vaccine market is huge. According to the data, in 2019, China's vaccine market will reach 42.5 billion yuan (6.1 billion US dollars), 4.4 US dollars per capita. Compared with the US market of 16 billion US dollars and 57.7 US dollars per capita, the development of domestic vaccine industry still has huge development space.

Policy also supports the development of the vaccine industry to ensure the supply of vaccines. On December 11, 2020, the SAMS State Administration of Municipal Supervision promulgated the "measures for the administration of batch issuance of biological products", which further improved the management measures for the determination of batch issuance institutions, batch issuance application, audit and inspection of biological products. The "measures" has been implemented on March 1, 2021, which means that China's batch issuance of biological products has entered a more standardized stage.

Pharmaceutical machinery industry probably be benefited

Vaccine commercialization involves R&D, production and sales. Among them, in the production process, with the acceleration of production expansion of vaccine enterprises, the industry believes that the demand for pharmaceutical machinery and raw and auxiliary packages is expected to grow.

It is understood that vaccine production generally requires fermentation, collection / inactivation, processing, preparation, filling and other processes, and the main node is configuration and filling. Considering the safety and quality problems of vaccines, vaccine enterprises also have higher requirements for relevant manufacturing and filling equipment.

With the growth of vaccine demand, pharmaceutical equipment is expected to grow rapidly.

In general, under the background of accelerating the commercialization of vaccines, pharmaceutical equipment is expected to usher in opportunities.